Polygenic Inheritance of Tourette Syndrome, Stuttering, Attention Deficit Hyperactivity, Conduct, and Oppositional Defiant Disorder: The Additive and Subtractive Effect of the Three Dopaminergic Genes - DRD2, DβH, and DAT1

American Journal of Medical Genetics - Seminars in Medical Genetics

Volumn 67, Issue 3, 1996, Pages 264-288

  Comings, David E ^a   Wu, S ^a   Chiu, Connie ^a   Ring, Robert H ^a   Gade, Radhika ^a   Ahn, Chul ^a   MacMurray, James P ^b   Dietz, George ^a   Muhleman, Donn ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b Jerry L Pettis VA Hospital   (United States)

Author keywords

ADHD; Attention deficit hyperactivity disorder; Conduct disorder; DAT1; Dopamine; DRD2; D H; Polygenic; Tourette syndrome; Transporter

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE BETA MONOOXYGENASE;

ALCOHOL ABUSE; ANXIETY; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; DOPAMINERGIC TRANSMISSION; GENETIC POLYMORPHISM; GENOTYPE; GILLES DE LA TOURETTE SYNDROME; MANIA; MARKER GENE; MINIMAL BRAIN DYSFUNCTION; MULTIFACTORIAL INHERITANCE; OBSESSION; PRIORITY JOURNAL; STUTTERING; TIC;

ADOLESCENT; ADULT; ALLELES; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CARRIER PROTEINS; DOPAMINE; DOPAMINE BETA-HYDROXYLASE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GENOTYPE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; PHYLOGENY; RECEPTORS, DOPAMINE D2; STUTTERING; TOURETTE SYNDROME;

EID: 0029947141     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19960531)67:3<264::AID-AJMG4>3.0.CO;2-N     Document Type: Article

References (144)

1. Amadeo S, Abbar M, Fourcade ML, Waksman G, Leroux MG, Madec A, Selin M, Champiat J-C, Brethome A, Leclaire Y, Castelnau D, Venisse J-L, Mallet J (1993): D2 dopamine receptor gene and alcoholism. J Psychiatr Res 27:173-179.
2. Anden NE, Atack CV, Svensen TH (1973): Release of dopamine from central noradrenaline and dopamine nerves by a dopamine β-hydroxylase inhibitor. J Neural Transm 34:93-100.
3. Aschauer HN, Meszaros K (1994): Schizophrenia and DNA-markers surrounding the dopamine beta-hydroxylase locus in chromosome 9q. Neuropsychopharmacol 10 Supplement Part 1:895S.
4. Austin LS, Lydiard RB, Ballenger JC, Cohen BM, Laraia MT, Zealberg JJ, Fossey MD, Ellinwood EH (1991): Dopamine blocking activity of clomipramine in patients with obsessive-compulsive disorder. Biol Psychiatry 30:225-232.
5. Axelrod J, Weinshilboum R (1972): Catecholamines. New Engl J Med 287:237-242.
6. Ballenger JC, Post RM, Jimerson D et al. (1983): Biochemical correlates of personality traits in normals: An exploratory study. Personality Individual Diff 4:615-625.
7. Baxter LR, Schwartz JM, Bergman KS, Szuba MP, Gruze BH, Mazziotta JC, Alazraki A, Selin CE, Ferng H-K, Munford P, Phelps ME (1992): Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry 49.681-689.
8. Blum K, Noble EP, Sheridan PJ, Montgomery A, Ritchie T, Jadadeeswaran P, Nogami H, Briggs AH, Cohn JB (1990): Allelic association of human dopamine D2 receptor gene in alcoholism. JAMA 263:2055-2059.
9. Blum K, Wood RC, Sheridan PJ, Chen T, Comings DE (1995): Dopamine D2 receptor gene variants: Association and linkage studies in impulsive, addictive and compulsive disorders. Pharmacogenetics 5:121-141.
10. Bolos AM, Dean M, Lucas-Derse S, Ramsburg M, Brown GL, Goldman D (1990): Population and pedigree studies reveal a lack of association between the dopamine D2 receptor gene and alcoholism. JAMA 26:3156-3160.
11. Botwinick CY, Quartermain D, Freedman LS, Hallock MF (1977): Some characteristics of amnesia induced by FLA-63, an inhibitor of dopamine beta hydroxylase. Pharmacol Biochem Behav 6:487-491.
12. Bowden CL, Deutsch CK, Swanson JM (1988): Plasma dopamine-beta-hydroxylase and platelet monoamine oxidase in attention deficit disorder and conduct disorder. J Am Acad Child Adolesc Psychiatry 27 171-174.
13. Buchsbaum MS, Murphy DL, Coursey RD, Lake CR, Zeigler MG (1978): Platelet monamine oxidase plasma dopamine-beta-hydroxylase and attention in a "biochemical high risk" sample. J Psychiatr Res 20186:18647-402.
14. Burd L, Fisher WW, Kerbeshian J, Arnold ME (1987): Is development of Tourette disorder a marker for improvement in patients with autism and other pervasive developmental disorders. J Am Acad Child Adolesc Psychiatry 26:162-165.
15. Carlsson A (1978): Antipsychotic drugs, neurotransmitters, and schizophrenia. Am J Psychiatry 135:164-173.
16. Cloninger SR (1994): Turning point in the design of linkage studies of schizophrenia. Am J Med Gen (Neuropsychol Genet) 54:83-92.
17. Comings DE, Comings BG (1984): Tourette's syndrome and attention deficit disorder with hyperactivity: Are they genetically related? J Am Acad Child Psychiatry 23:138-146.
18. Comings DE, Comings BG, Devor EJ, Cloninger CR (1984): Detection of major gene for Gilles de la Tourette syndrome. Am J Hum Genet 36:586-600.
19. Comings DE, Comings BG (1985): Tourette syndrome: Clinical and psychological aspects of 250 cases. Am J Hum Genet 37:435-450.
20. Comings DE, Comings BG, Dietz G, Muhleman D, Okada TA, Sarinana F, Simmer R, Sparks R, Crist M, Stock D (1986): Linkage studies in Tourette syndrome. Am J Hum Genet 39:A151.
21. Comings DE, Comings BG (1987a): A controlled study of Tourette syndrome. II. Conduct Am J Hum Genet 41:742-760.
22. Comings DE, Comings BG (1987b): A controlled study of Tourette syndrome. I. Attention-deficit disorder, learning disorders, and school problems. Am J Hum Genet 41:701-741.
23. Comings DE, Comings BG, Knell E (1989): Hypothesis: Homozygosity in Tourette syndrome. Am J Med Genet 34:413-421.
24. Comings DE (1990a): "Tourette Syndrome and Human Behavior." Duarte, CA: Hope Press, pp 1-828.
25. Comings DE (1990b): Blood serotonin and tryptophan in Tourette syndrome. Am J Med Genet 36:418-430.
26. Comings DE, Himes JA, Comings BG (1990): An epidemiological study of Tourette syndrome in a single school district. J Clin Psychiatry 51:463-469.
27. Comings DE, Comings BG (1991a): Common genes for spectrum disorders: Implications for psychiatric genetics. Psychiat Genet 2:5-6.
28. Comings DE, Comings BG (1991b): Clinical and genetic relationships between autism-PDD and Tourette syndrome: A study of 19 cases. Am J Med Genet 39:180-191.
29. Comings DE, Comings BG, Muhleman D, Dietz G, Shahbahrami B, Tast D, Knell E, Kocsis P, Baumgarten R, Kovacs BW, Levy DL, Smith M, Kane JM, Lieberman JA, Klein DN, MacMurray J, Tosk J, Sverd J, Gysin R, Flanagan S (1991): The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. JAMA 266:1793-1800.
30. Comings DE (1992): The D2 dopamine receptor and Tourette's syndrome. JAMA 267:652
31. Comings DE, Comings BG (1992): Alternative hypotheses on the inheritance of Tourette syndrome. Adv Neurol 58:189-199.
32. Comings DE (1994a):The role of genetic factors in human sexual behavior based on studies of Tourette syndrome and ADHD probands and their relatives. Am J Med Genet (Neuropsychol Genet) 54: 227-241.
33. Comings DE (1994b). Genetic factors in substance abuse based on studies of Tourette syndrome and ADHD probands and relatives. I. Drug abuse. Drug Alcohol Dependence 35:1-16.
34. Comings DE (1994c): Genetic factors in substance abuse based on studies of Tourette syndrome and ADHD probands and relatives. II. Alcohol abuse Drug Alcohol Dependence 35:17-24.
35. Comings DE (1994d): Candidate genes and association studies in psychiatry. Letter to the editor. Am J Med Gen (Neuropsychol Genet) 54:324.
36. Comings DE, Muhleman D, Ahn C, Gysin R, Flanagan SD (1994): The dopamine D2 receptor gene: A genetic risk factor in substance abuse. Drug Alcohol Dependence 34:175-180.
37. Comings DE (1995a): Genetic factors in depression based on studies of Tourette syndrome and Attention Deficit Hyperactivity Disorder probands and relatives. Am J Med Gen (Neuropsychol Genet) 60: 111-121.
38. Comings DE (1995b): Dopamine D2 receptor and Tourette syndrome. Arch Neurol 52:441-442.
39. Comings DE (1995c): The haplotype relative risk technique lacks power in polygenic inheritance. 1995 World Congress Psychiatric Genetics 5:103.
40. Comings DE (1995d): The role of genetic factors in conduct disorder based on studies of Tourette syndrome and ADHD probands and their relatives. J Dev Behav Pediatr 16:142-157.
41. Comings DE (1995e): Tourette syndrome: A hereditary neuropsychiatric spectrum disorder. Ann Clin Psychiatry 6:235-247.
42. Comings DE (1995f): Polygenic inheritance of psychiatric disorders: A hypothesis. 1995 World Congress Psychiatric Genetics 5:248.
43. Comings DE (1996): Genetic mechanisms in neuropsychiatrie disorders. In Blum K, Noble EP, Sparks RS, Sheridan PJ (eds): "Handbook of Psychoneurogenetics." Boca Raton, FL: CRC Press, (in press).
44. Comings DE, Muhleman D, Dietz G, Sherman M, Forest G (1996a): Sequence of human tryptophan 2,3-dioxygenase: Presence of a glucocorticoid response-like element composed of a GTT repeat and an intronic CCCCT repeat. Genomics 29:390-396.
45. Comings DE, Muhleman D, Gade R, Chiu C, Wu H, Dietz G, Winn-Dean E, Ferry L, Rosenthal RJ, Lesieur HR, Rugle L, Sverd J, Johnson P, MacMurray JP (1996b): Exon and intron mutations in the human tryptophan 2,3-dioxygenase gene and their potential association with Tourette syndrome, substance abuse and other psychiatric disorders. Pharmacogenetics (in press).
46. Comings DE, Rosenthal RJ, Lesieur HR, Rugle L, Muhleman D, Chiu C, Dietz G, Gade R (1996c): A study of the dopamine D2 receptor gene in pathological gambling. Pharmacogenetics (in press).
47. Comings DE, Comings BG (1987): A controlled study of Tourette syndrome. I-VII. Am J Hum Genet 41:701-866.
48. Comings DE, Comings BG (1993). Comorbid Behavioral Disorders. In Kurlan R (ed): "Tourette Syndrome and Related Disorders." New York: Marcel-Decker, pp 111-147.
49. Cook EH, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE, Leventhal BL (1995): Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 56:993-998.
50. d'Amato T, Leboyer M, Malafosse A, Samolyk D, Lamouroux A, Junien C, Mallet J (1989): Two Taq I dimorphic sites at the human b-hydroxylase locus. Nucleic Acids Res 17:5871.
51. Delgado PL, Goodman WK, Price LH, Heninger GR, Charney DS (1990): Fluvoxamine pimozide treatment of concurrent Tourette's and obsessive-compulsive disorder. Br J Psychiatry 157:762-765
52. Devor EJ, Grandy DK, Civelli O, Litt M, Burgess AK, Isenberg KE, van de Wetering BJM, Oostra B (1990): Genetic linkage is excluded for the D2-dopamine receptor lambda-Hd2G1 and flanking loci on chromosome 11Q22-Q23 in Tourette syndrome. Hum Hered 40:105-108.
53. Devor EJ (1992): D2-dopamine receptor and neuropsychiatrie illness [letter]. JAMA 267:651.
54. "Diagnostic and Statistical Manual of Mental Disorders. Third Edition" (1980): Washington DC: American Psychiatric Association.
55. "Diagnostic and Statistical Manual of Mental Disorders. Third Edition-Revised" (1987): Washington DC: American Psychiatric Association
56. Dunn O, Clark V (19950: "Applied Statistics: Analysis of Variance and Regression," 2nd Edition. New York: John Wiley and Sons, Inc.
57. Falk CT, Rubinstein P (1987): Haplotype relative risks: An easy reliable way to construct a proper control sample for risk calculations. Ann Hum Genet 51:227-233.
58. Faraone SV, Biederman J, Milberger S (1994): An exploratory study of ADHD among second-degree relatives of ADHD children. Biol Psychiatry 35:398-402.
59. Flexner JB, Flexner LB (1976); Effect of two inhibitors of dopamine β-hydroxylase on maturation of memory in mice. Pharmacol Biochem Behav 5:117-121.
60. Flexner JB, Flexner LB, Church AC (1983): Studies on memory: The cerebral spread of an engram in mice as affected by inhibitors of dopamine β-hydroxylase. Pharmacol Biochem Behav 18: 519-523.
61. Folstein S, Rutter M (1977): Infantile autism: A genetic study of 21 twin pairs. J Child Psychol Psychiatry 18:297-321.
62. Gabel S, Stadler J, Bjorn J, Shindledecker R, Bowden C (1993): Dopamine-beta-hydroxylase in behaviorally disturbed youth. Biol Psychiatry 34:434-442.
63. Gadow KD, Sprafkin J (1994). "Child Symptom Inventories Manual." Stony Brook, NY: Checkmate Plus, Ltd., pp 1-115.
64. Galvin M, Shekhar A, Simon J, Stilwell B, TanEyck R, Laite G, Karwisch G, Blix S (1991): Low dopamine-beta-hydroxylase: A biological sequela of abuse and neglect? Psychiatry Res 39:1-11.
65. Gary T, Robertson D (1994): Lessons learned from dopamine β-hydroxylase deficiency in humans. NIPS 9:35-39.
66. 2 receptor gene in alcoholism or schizophrenia. JAMA 271:204-208.
67. Gelernter J (1995): DRD4 alleles are associated with Tourette's syndrome. Psychiat Genet 5:S20.
68. Gelernter J, Pakstis AJ, Pauls DL, Kurlan R, Gancher ST, Civelli O, Grandy D, Kidd KK (1990): Gilles-de-La-Tourette syndrome is not linked to D2-dopamine receptor. Arch Gen Psychiatry 47: 1073-1077.
69. Gelernter J, O'Malley SO, Risch N, Kranzler HR, Krystal J, Merikangas K, Kennedy JL, Kidd KK (1991): No association between an allele at the D2 dopamine receptor gene (DRD2) and alcoholism. JAMA 266:1801-1807.
70. Gelernter J, Pauls D, Leckman J, Kurlan R (1992): Evidence that D2 dopamine receptor alleles do not influence severity of Tourette's syndrome. Am J Psychiatry (abstracts):127-128
71. Gelernter J, Krazler HR, Satel SL, Rao PA (1994a): Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia. Neuropsychopharmacol 11:195-200.
72. Gelernter J, Pauls DL, Leckman J, Kidd KK, Kurlan R (1994b): D2 dopamine receptor alleles do not influence severity of Tourette's syndrome. Arch Neurol 51:397-400.
73. Gelernter J, Leckman J, Pauls D, Kidd KK, Kurlan R (1995): Dopamine D2 receptor and Tourette syndrome. Reply. Arch Neurol 52:442-443.
74. Gessa GL, Tagiamonte A (1975): Role of brain serotonin and dopamine in male sexual behavior. In Sandler M, Gessa GL (eds): "Sexual Behavior: Pharmacology and Biochemistry." New York: Raven Press, pp 117-128.
75. Goodwin FK, Jamison KR (1990): "Manic-Depressive Illness." New York: Oxford University Press, pp 1-938.
76. Gottesman II (1991): "Schizophrenia Genetics: The Origins of Madness." New York, NY: Freeman.
77. Grayson P, Carlson G (1991): The utility of a DSM-III-R based checklist in screening child psychiatric patients. J Am Acad Child Adolesc Psychiatry 30:669-673.
78. Heutink P, van de Wetering BJM, Breedveld GJ, Oostra BA (1992): Genetic study on Tourette syndrome in the Netherlands. Adv Neurol 58:167-172.
79. Isquierdo I, Beamish D, Anisman H (1979): Effect of an inhibitor of dopamine-beta-hydroxylase on the acquisition and retention of four different avoidance tasks in mice. Psychopharmacology (Berlin) 63:173-178.
80. Karp RW (1994): Genetic studies in alcohol research. Am J Med Gen (Neuropsychol Genet) 54:304-308.
81. Khanatzian IEJ, Gawin FH, Riordan C, Kleber HD (1984): Methylphenidate treatment of cocaine dependence: A preliminary report. J Substance Abuse Issues 1:107-112.
82. King R (1986): Motivational diversity and mesolimbic dopamine: A hypothesis concerning temperament. In Plutchik R, Kellerman H (eds): "Emotion Theory, Research, and Experience." New York: Academic Press, Inc., pp 363-380.
83. Knell E, Comings DE (1993): Tourette syndrome and attention deficit hyperactivity disorder. Evidence for a genetic relationship. J Clin Psychiatry 54:331-337.
84. Kurlan R, Eapen V, Stern J, McDermott MP, Robertson MM (1994a): Bilineal transmission in Tourette's syndrome families. Neurology 44:2336-2342.
85. Kurlan R, Whitemore D, Irvine C, McDermott MP, Como PG (1994b): Tourette's syndrome in a special education population: A pilot study involving a single school district. Neurology 44:699-702.
86. Lamouroux A, Vigny A, Faucon Biguet N, Darmon MC, Frank R, Henry JP (1987): The primary structure of dopamine-beta-hydroxylase: insights into the relationship between the soluble and the membrane-bound forms of the enzyme. EMBO J 6:3931-3937.
87. Lamouroux A, Houhou L, Biguet NF, Serck-Hanssen G, Guibert B, Icard-Liepkalns C, Mallet J (1993): Analysis of the human dopamine β-hydroxylase promoter: Transcriptional induction by cyclic AMP. J Neurochemistry 60:364-367.
88. Lerner P, Goodwin FK, van Kammen DP, Post RM, Major LF, Ballenger JC, Lovenberg W (1978): Dopamine-β-hydroxylase in the cerebrospinal fluid of psychiatric patients. Biol Psychiatry 13:685-694
89. Major LF, Lerner P, Goodwin FK, Ballenger JC, Brown GL, Lovenberg W (1980): Dopamine β-hydroxylase in CSF. Arch Gen Psychiatry 37:308-310.
90. Malison RT, McDougle CJ, van Dyck CH, Scahill L, Baldwin RM, Seibyl JP, Price LH, Leckman JF, Innis RB (1995): [123]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder. Am J Psychiatry 152:1359-1361.
91. Modell JG, Mountz JM, Curtis GC, Greden JF (1989): Neurophysiologic dysfunction in basal ganglia/limbic striatal and thalamocotrical circuits as a pathogenetic mechanism of obsessive-compulsive disorder. J Neuropsychiatry 1:27-36.
92. Murray TJ, Kelly P, Campbell L, Stefanik K (1977): Haloperidol in the treatment of stuttering. Br J Psychiatry 130:370-373.
93. Noble EP, Blum K, Ritchie T, Montgomery A, Sheridan PJ (1991): Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch Gen Psychiatry 48:648-654
94. Noble EP (1993): The D2 dopamine receptor gene: A review of association studies in alcoholism. Behav Genet 23.119-129.
95. 2 dopamine receptor gene with cocaine dependence. Drug Alcohol Depend 33:271-285.
96. Nöthen MM, Hebebrand J, Knapp M, Hebebrand K, Camps A, von Gontard A, Wettke-Schäfer R, Cichon S, Poustka F, Schmidt M, Lehmkuhl G, Remschmidt H, Propping P (1994): Association analysis of the dopamine D2 receptor gene in Tourette's syndrome using the haplotype relative risk method. Am J Med Gen (Neuropsych Genet) 54:249-252.
97. O'Hara BF, Smith SS, Bird G, Persico AM, Suarez B, Cutting GR, Uhl GR (1993): Dopamine D2 receptor RFLPs, haplotypes and their association with substance use in Black and Caucasian Research Volunteers. Hum Genet 43:209-218.
98. O'Rourke DH, Gottesman II, Suarez BK, Rice J, Reich T (1982): Refutation of the general single locus model for the etiology of schizophrenia. Am J Hum Genet 34:630-649.
99. Ott J (1989): Statistical properties of the haplotype relative risk. Genet Epidemiol 6:127-130.
100. Pakstis AJ, Heutink P, Pauls DL, Kurlan R, van de Wetering BJM, Leckman JF, Sandkuyl LA, Kidd JR, Breedveld GJ, Castiglione CM, Weber J, Sparkes RS, Cohen DJ, Kidd KK, Oostra BA (1991): Progress in the search for genetic linkage with Tourette syndrome: An exclusion map covering more than 50-percent of the autosomal genome. Am J Hum Genet 48:281-294.
101. Pauls DL, Leckman JF (1986): The inheritance of Gilles de la Tourette's syndrome and associated behaviors. Evidence for autosomal dominant transmission. N Engl J Med 315:993-997.
102. Pauls DL, Pakstis AJ, Kurlan R, Kidd KK, Leckman JF, Cohen DJ, Kidd JR, Como P, Sparkes R (1990): Segregation and linkage analyses of Tourette syndrome and related disorders. J Am Acad Child Psychiatry 29:195-203.
103. Perry SE, Summar ML, Phillips JA, Robertson D (1991): Linkage analysis of the human dopamine β-hydroxylase gene. Genomics 10:493-495.
104. Persico AM, Vandenbergh DJ, Smith SS, Uhl GR (1993): Dopamine transporter gene polymorphisms are not associated with polysubstance abuse. Biol Psychiatry 34:265-267.
105. Pliszka SR, Rogeness GA, Medrano MA (1988a): DBH, MHPG and MAO in children with depressive, anxiety and conduct disorders: Relationship to diagnosis and symptoms ratings. Psychiatry Res 24:35-44.
106. Pliszka SR, Rogeness GA, Renner P, Sherman J, Broussard T (1988b): Plasma neurochemistry in juvenile offenders. J Am Acad Child Adolesc Psychiatry 27:588-594.
107. Plomin R (1990): The role of inheritance in behavior. Science 248: 183-188
108. Plomin R, Owen MJ, Mcguffin P (1994): The genetic basis of complex human behaviors. Science 264:1733-1739.
109. Price RA, Kidd KK, Cohen DJ, Pauls DL, Leckman JF (1985): A twin study of Tourette syndrome. Arch Gen Psychiatry 42:815-820.
110. Prins D, Mandelkorn T, Cerf FA (1980): Principal and differential effects of haloperidol and placebo treatments upon speech disfluencies in stutterers. J Speech Hearing Res 23:614-629.
111. Quay HC (1986): The behavioral reward and inhibition system in childhood behavior disorder. In Bloomingdale LM (ed): "Attention Deficit Disorder 3." New York: Spectrum.
112. Randrup A, Scheel-Kruger J (1966): Diethyldithiocarbamate and stereotyped behavior. J Pharm Pharmacol 18:752.
113. Rauch SL, Jenike MA, Alpert N, Baer L, Breiter CR, Savage CR, Fischman AJ (1994): Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch Gen Psychiatry 51:62-70.
114. Ritz MC, Cone EJ, Kuhar MJ (1990): Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: A structure-activity study. Life Sci 46:635-645.
115. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ (1992): Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237.1219-1223
116. Robins LN, Helzer J, Croughan J, Ratclif KS (1981): National Institute of Health diagnostic interview schedule. Arch Gen Psychiatry 38: 381-309.
117. Rogeness GA, Hernandez JM, Macedo CA, Mitchell EL, Amrung SA, Harris WR (1984): Clinical characteristics of emotionally disturbed boys with very low activities of dopamine β-hydroxylase. J Am Acad Child Adolesc Psychiatry 23:203-208.
118. Rogeness GA, Hernandez JM, Macedo CA, Amrung SA, Hoppe SK (1986): Near-zero plasma dopamine-β-hydroxylase and conduct disorder in emotionally disturbed boys. J Amer Acad Child Psychiat 25:521-527.
119. Rogeness GA, Javors MA, Maas JW, Macedo CA, Fisher C (1987): Plasma doparnine-beta-hydroxylase, HVA, MHPG and conduct disorder in emotionally disturbed boys. Biol Psychiatry 22:1155-1158.
120. Rogeness GA, Maas JW, Javors MA, Macedo CA, Harris WR, Hoppe SK (1988): Diagnoses, catecholamine metabolism, and plasma dopamine-β-hydroxylase. J Am Acad Child Adolesc Psychiatry 27:121-125.
121. Rothman KKJ (1990): No adjustments are needed for multiple comparisons. Epidemiology 1:43-46.
122. Roy A, Brockington K (1987): Plasma dopamine-beta-hydroxylase in depressed patients and controls. Neuropsychobiology 18:57-59.
123. Sarkar G, Kapelner S, Grandy DK, Marchionni M, Civelli O, Sobell J, Heston L, Sommer SS (1991): Direct sequencing of the dopamine D2 receptor (DRD2) in schizophrenics reveals three polymorphisms but no structural change in the receptor. Genomics 11:8-14.
124. Schmidt PL (1992): What do data really mean? Research findings, meta-analysis, and cumulative knowledge in psychology. Am Psychologist 47:1173-1181.
125. Schwab S, Soyka M, Niederecker N, Ackenheil M, Scherer J, Widenauer DB (1991): Allelic association of human dopamine D2-receptor DNA polymorphism ruled out in 45 alcoholics. Am J Hum Genet 49 (suppl):203A
126. Schweri MM, Thurkauf A, Mattson MV, Rice KC (1992): Fourphit: A selective probe for the methylphenidate binding site on the dopamine transporter. J Pharmacol Exp Ther 261:936-942.
127. Shaywitz BA, Yager RD, Klopper JH (1976): Selective brain dopamine depletion in developing rats: An experimental model of minimal brain dysfunction. Science 191:305-307.
128. Singer HS, Hahn IH, Moran TH (1991): Abnormal dopamine uptake sites in postmortem striatum from patients with Tourette's syndrome Ann Neurol 30:558-562.
129. Smith SS, O'Hara BF, Persico AM, Gorelick DA, Newlin DB, Vlahov D, Solomon L, Pickins R, Uhl GR (1992): Genetic vulnerability to drug abuse. The D2 dopamine receptor Taq I B1 restriction fragment length polymorphism appears more frequently in polysubstance abusers. Arch Gen Psychiatry 49: 723-727.
130. Snyder SH (1976): The dopamine hypothesis of schizophrenia: Focus on the dopamine receptor. Am J Psychiatry 130:61-67.
131. Sverd J (1991): Tourette's syndrome and autistic spectrum disorders: A significant relationship. Am J Med Genet 39:173-179.
132. Tsui L-C (1994): Genetic linkage study of Gilles de la Tourette syndrome. TSA Permanent Research Fund Recipients. TSA Newsletter.
133. Uhl G (1990): Parkinson's disease: Neurotransmitter and neurotoxin receptors and their genes. Eur J Neurol 30:21-30.
134. Umberkoman-Wita B, Vogel WH, Wita PJ (1981): Some biochemical and behavioral (sensation seeking) correlates in healthy adults. Res Commun Psychol Psychiat Behav 6:303-316.
135. Valzelli L (1981): "Psychobiology of Aggression and Violence." New York: Raven Press, pp 1-248.
136. Vandenbergh DJ, Persico AM, Hawkins AL, Griffin CA, Li X, Jabs EW, Uhl GR (1992a): Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 14: 1866-1868.
137. Vandenbergh DJ, Persico AM, Uhl GR (1992b): A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic Taq I RFLPs. Molec Brain Res 15:161-166.
138. Vuchetich JP, Dunnette J, Lunetta KL, Weinshilboum RM, Price RA (1991): Inheritance of human plasma dopamine-β-hydroxylase thermal stability. Genet Epidemiol 8:237-251.
139. Weinshilboum RM, Raymond FA, Elveback LR, Weidman WH (1973): Serum dopamine-β-hydroxylase activity: Sibling-sibling correlation. Science 181:943-945.
140. Wernshilboumn RM (1983): Biochemical genetics of catecholamines in man. Mayo Clin Proc 58:319-330.
141. Wilson AF, Elston RC, Siervogek RM, Tran LD (1988): Linkage of a gene regulation dopamine β-hydroxylase activity and the ABO blood group linkage. Am J Hum Genet 42:160-166.
142. Wilson AF, Elston RC, Mallott DB, Tran LD, Winokur G (1992): The current status of genetic linkage studies of alcoholism and unipolar depression. Psychiat Genet 2:107-124.
143. Works P, Seeman W, Haller D (1974): "The Actuarial Use of the MMPI With Adolescents and Adults." Baltimore: Williams and Wilkins.
144. Zohar AH, Ratzoni G, Pauls DL, Apter A, Bleich A, Kron S, Rappaport M, Weizman A, Cohen DJ (1992): An epidemiological study of obsessive-compulsive disorder and related disorders in Israeli adolescents. J Am Acad Child Adolesc Psychiatry 31:1057-1061.